Home DailyMed 7742cb31-704b-4038-bd3e-e1992f80efb7 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 02:04:50 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021323-001 LEXAPRO ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 N021323-002 LEXAPRO ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 N021323-003 LEXAPRO ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N021323-001 NPP 2026-05-12 N021323-002 NPP 2026-05-12 N021323-003 NPP 2026-05-12
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021323-002 LEXAPRO EQ 10MG BASE TABLET / ORAL AB RLD 2002-08-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021323-003 LEXAPRO EQ 20MG BASE TABLET / ORAL AB RLD, RS 2002-08-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021323-001 LEXAPRO EQ 5MG BASE TABLET / ORAL AB RLD 2002-08-14 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 129 observed states.
Observed Orange Book patent history# Patent history page 1 of 7 · 252 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-001 6916941 2022-08-12 Drug substance, Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-001 7420069 2022-08-12 Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-001 6916941*PED 2023-02-12 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-001 7420069*PED 2023-02-12 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-002 6916941 2022-08-12 Drug substance, Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-002 7420069 2022-08-12 Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-002 6916941*PED 2023-02-12 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-002 7420069*PED 2023-02-12 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-003 6916941 2022-08-12 Drug substance, Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-003 7420069 2022-08-12 Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-003 6916941*PED 2023-02-12 Pediatric extension 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021323-003 7420069*PED 2023-02-12 Pediatric extension 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021323-001 6916941 2022-08-12 Drug substance, Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-001 7420069 2022-08-12 Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-001 6916941*PED 2023-02-12 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-001 7420069*PED 2023-02-12 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-002 6916941 2022-08-12 Drug substance, Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-002 7420069 2022-08-12 Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-002 6916941*PED 2023-02-12 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-002 7420069*PED 2023-02-12 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-003 6916941 2022-08-12 Drug substance, Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-003 7420069 2022-08-12 Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-003 6916941*PED 2023-02-12 Pediatric extension 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021323-003 7420069*PED 2023-02-12 Pediatric extension 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021323-001 6916941 2022-08-12 Drug substance, Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-001 7420069 2022-08-12 Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-001 6916941*PED 2023-02-12 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-001 7420069*PED 2023-02-12 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-002 6916941 2022-08-12 Drug substance, Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-002 7420069 2022-08-12 Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-002 6916941*PED 2023-02-12 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-002 7420069*PED 2023-02-12 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-003 6916941 2022-08-12 Drug substance, Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-003 7420069 2022-08-12 Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-003 6916941*PED 2023-02-12 Pediatric extension 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021323-003 7420069*PED 2023-02-12 Pediatric extension 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021323-001 6916941 2022-08-12 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021323-001 7420069 2022-08-12 Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021323-001 6916941*PED 2023-02-12 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021323-001 7420069*PED 2023-02-12 Pediatric extension 74a2ff9319b5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 69 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.